drugset / Trial / NCT06223074
Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration
Phase 2
Enrolling by invitation
80 enrolled
Universidad Nacional Autonoma de Mexico
Instituto Nacional de Neurología y Neurocirugía · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This Clinical Trial evaluates the nasal administration of Methylprednisolone as a treatment strategy for Acute Relapses in Multiple Sclerosis
Timeline
- Start
- 2023-01-09
- Primary completion
- 2026-02-25
- Completion
- 2026-07-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylprednisolone | Other / unclassified | 1 g | Intranasal |